pharma& to acquire product business of Clovis Oncology for $176m.

Synopsis

pharma&, a pharmaceutical manufacturing firm, agreed to acquire product business of Clovis Oncology, a biotechnology research, for $176m.

Principals

Clovis Oncology (product Business)

Pharma& Schweiz

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

perella weinberg partners

HQ - New York

financial advisors

vendor

365

Deals

£ 697.07 B

Total Value

covington & burling

HQ - Washington DC

legal advisors

vendor

303

Deals

£ 396.28 B

Total Value